Page last updated: 2024-10-23

bisbenzimidazole and Glial Cell Tumors

bisbenzimidazole has been researched along with Glial Cell Tumors in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaur, N1
Ranjan, A1
Tiwari, V1
Aneja, R1
Tandon, V1
Yoshimura, S1
Sakai, H1
Ohguchi, K1
Nakashima, S1
Banno, Y1
Nishimura, Y1
Sakai, N1
Nozawa, Y1

Other Studies

2 other studies available for bisbenzimidazole and Glial Cell Tumors

ArticleYear
DMA, a bisbenzimidazole, offers radioprotection by promoting NFκB transactivation through NIK/IKK in human glioma cells.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Bisbenzimidazole; Cell Line, Tumor; Cell Survival; Glioma; Humans; I-kappa B Kinase; NF-kappa B; NF-

2012
Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat C6 glial cells.
    Journal of neurochemistry, 1997, Volume: 69, Issue:2

    Topics: ADP-Ribosylation Factors; Animals; Apoptosis; Bisbenzimidazole; Cell Survival; Ceramides; DNA Fragme

1997